Clinical Trial Update: Aspirin-Myocardial Infarction Study (AMIS) [Phase 3]

View source ↗

Summary

The Phase 3 Aspirin-Myocardial Infarction Study (AMIS) has completed. It was sponsored by the National Heart, Lung, and Blood Institute (NHLBI) and evaluated as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED